Supernus Pharmaceuticals Inc. | Key People and Executives
Charles W. Newhall
Chairman
Jack A. Khattar
President, CEO, Secretary & Director
Georges Gemayel
Independent Director
John M. Siebert
Independent Director
Frederick M. Hudson
Independent Director
Charles W. Newhall
Chairman
Jack A. Khattar
President, CEO, Secretary & Director
Gregory S. Patrick
Chief Financial Officer & Vice President
Frank Mottola
Vice President-Quality & Information Technology
Padmanabh P. Bhatt
Chief Scientific Officer & Senior Vice President
Stefan K. F. Schwabe
Chief Medical Officer, EVP-Research & Development
Bryan A. Roecklein
Vice President-Corporate Development
Taylor Raiford
Vice President-Sales
Todd Horich
Vice President-Marketing
Tami Tillotson Martin
Vice President-Regulatory Affairs
Georges Gemayel
Independent Director
John M. Siebert
Independent Director
Frederick M. Hudson
Independent Director
| Address |
1550 East Gude Drive
Rockville Maryland 20850
United States
|
|
Employees
|
- |
| Website |
http://www.supernus.com |
| Updated |
07/08/2019 |
| Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. Its neurology portfolio consists of Oxtellar XR and Trokendi XR, which treats patients with epilepsy. The firm also develops product candidates for the treatment of impulsive aggression and for the treatment of attention deficit hyperactivity disorder. |
